Down-Regulating Receptor Interacting Protein Kinase 1 (RIP1) Promotes Oxaliplatin-Induced Tca8113 Cell Apoptosis

@inproceedings{Shan2015DownRegulatingRI,
  title={Down-Regulating Receptor Interacting Protein Kinase 1 (RIP1) Promotes Oxaliplatin-Induced Tca8113 Cell Apoptosis},
  author={Baozhong Shan and Feng Ma and Mingguo Wang and Xin Xu},
  booktitle={Medical science monitor : international medical journal of experimental and clinical research},
  year={2015}
}
BACKGROUND Oxaliplatin is a crucial chemotherapy drug that plays an important role in colorectal cancer and oral cancer treatment. However, the molecular mechanism of oxaliplatin in killing tongue squamous cell cancer cells is still unknown. This paper investigates the mechanism of by which oxaliplatin regulates tongue squamous cell carcinoma Tca8113 cell survival and death. MATERIAL AND METHODS Tca8113 was treated with 1 μmol/L oxaliplatin for 24 h. Tca8113 cell proliferation and apoptosis… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

[Small interfering RNA-mediated RIP1 knockdown enhances L-OHP sensitivity of human oral squamous carcinoma cells].

  • Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • 2013
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Oxaliplatin triggers necrosis as well as apoptosis in gastric cancer SGC-7901 cells.

  • Biochemical and biophysical research communications
  • 2015
VIEW 1 EXCERPT

Similar Papers